The two-dose COVID-19 Pfizer vaccine is the first to be licensed and receive full approval from the US Food and Drug and Administration (FDA).
In the race to find a precaution against coronavirus, that has adversely affected the world, the vaccine had initially been approved for emergency use. The dosage is metered in two jabs, three weeks apart.
With so many anti-vaxxer’s spreading false information about vaccines not receiving the correct authorisation before being administered – this important FDA approval will create more vaccine mandates for organisations and employers.
In a press statement, the FDA confidently said the review for approval was gathered from data of 40 000 people and the vaccine will not be marketed as Comirnaty.
It has found to be 91% effective in preventing coronavirus and Acting FDA commissioner Janet Woodcock said that the public “can be very confident” the vaccine meets high safety, effectiveness and manufacturing quality standards.
The FDA announcement has now triggered national approval – the US military said they would officially require all 1.3-million active duty US troops to get vaccinated.
The next step is the licensing process and now that it has been approved, it will assist with increasing rates of vaccinations across the world.